浏览全部资源
扫码关注微信
异基因造血干细胞移植后患者口腔及肠道菌群与早期胃肠道急性移植物抗宿主病的关系
Association of intestinal and oral microbiota with acute graft versus host disease of the gastrointestinal tract in patients after allogeneic hematopoietic stem cell transplantation
- 陆军军医大学学报 2024年46卷第4期 页码：331-339
- 作者机构：
1.610072 成都，四川省医学科学院·四川省人民医院(电子科技大学医学院)血液内科
2.310012 杭州，浙江省立同德医院检验科
- 作者简介：
[黄晓兵，E-mail: huangxiaobing@med.uestc.edu.cnHUANG Xiaobing, E-mail: huangxiaobing@med.uestc.edu.cn
- 基金信息：成都市科技局技术创新项目(2019-YF05-00638-S1V)
DOI：10.16016/j.2097-0927.202310041
中图分类号： R372;R392.8;R574收稿：2023-10-12，
修回：2024-01-02，
纸质出版：2024-02-28
- 稿件说明：
移动端阅览
赖静, 傅鑫, 李成龙, 等. 异基因造血干细胞移植后患者口腔及肠道菌群与早期胃肠道急性移植物抗宿主病的关系[J]. 陆军军医大学学报, 2024,46(4):331-339.
Jing LAI, Xin FU, Chenglong LI, et al. Association of intestinal and oral microbiota with acute graft versus host disease of the gastrointestinal tract in patients after allogeneic hematopoietic stem cell transplantation[J]. Journal of Army Medical University, 2024, 46(4): 331-339.
赖静, 傅鑫, 李成龙, 等. 异基因造血干细胞移植后患者口腔及肠道菌群与早期胃肠道急性移植物抗宿主病的关系[J]. 陆军军医大学学报, 2024,46(4):331-339. DOI： 10.16016/j.2097-0927.202310041.
Jing LAI, Xin FU, Chenglong LI, et al. Association of intestinal and oral microbiota with acute graft versus host disease of the gastrointestinal tract in patients after allogeneic hematopoietic stem cell transplantation[J]. Journal of Army Medical University, 2024, 46(4): 331-339. DOI： 10.16016/j.2097-0927.202310041.
摘要
目的
2
初步探讨异基因造血干细胞移植(allogeneic hematopoietic stem cell transplantation
allo-HSCT)患者肠道菌群及口腔菌群的变化与早期胃肠道急性移植物抗宿主病(acute graft versus host disease
aGVHD)之间的关联
寻找可能有效的生物学标志物。
方法
2
选取2021年9月至2023年6月在四川省人民医院血液内科接受allo-HSCT后1个月内发生胃肠道aGVHD的10例急性白血病患者
收集其aGVHD前后粪便样本与唾液样本
采用16S rRNA测序分析方法
研究早期胃肠道aGVHD发生前后肠道菌群、口腔菌群的差异性改变。
结果
2
① 肠道菌群中拟杆菌属减少、肠球菌属及肠杆菌科增加与早期上消化道aGVHD发生呈正相关(
P
<
0.05)
而口腔菌群整体微生物多样性无显著差异(
P
>
0.05)。②胃肠道aGVHD前后肠道菌群LEfSe分析发现克雷伯杆菌属、肠球菌属增加
大肠埃希菌减少; 口腔菌群LEfSe分析发现存在差异显著10个微生物标志物
其中γ-变形菌纲的差异较为显著。③肠道菌群β多样性差异显著(
P
=0.03)
而口腔菌群α、β多样性无显著差异。
结论
2
Allo-HSCT患者发生早期胃肠道aGVHD前后肠道菌群存在显著差异
可能与口腔菌群变化有关。
Abstract
Objective
2
To preliminarily investigate the association between changes in intestinal microbiota and oral microbiota of allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients and early gastrointestinal acute graft versus host disease (aGVHD)
and try to explore potentially effective biomarkers and provide theoretical basis for early prediction and intervention of gastrointestinal aGVHD.
Methods
2
Ten acute leukemia patients who developed gastrointestinal aGVHD within 1 month after receiving allo-HSCT in Department of Hematology of Sichuan Provincial People's Hospital from September 2021 to June 2023 were enrolled
and their fecal samples and saliva samples before and after the aGVHD were collected.16S rRNA sequencing analysis was applied for the differential changes in intestinal and oral microbiota before and after the development of early gastrointestinal aGVHD.
Results
2
① A decrease in
Bacteroides spp
.and an increase in
Enterococcus spp
.and
Enterobacteriaceae spp
.in the intestinal microbiota were positively correlated with the occurrence of early upper gastrointestinal aGVHD (
P
<
0.05)
whereas no significant difference was observed in the overall microbial diversity of the oral microbiota (
P
>
0.05).② LEfSe analysis of the intestinal microbiota before and after gastrointestinal aGVHD revealed an increase in
Klebsiella spp
.and
Enterococcus spp
.and a decrease in
Escherichia coli
; In the oral microbiota
LEfSe analysis revealed 10 microbial markers with significant difference
of which Gamma proteobacteria was the most significant.③ The difference in β-diversity of the intestinal microbiota was significant (
P
=0.03)
whereas there was no significant difference in the α-and β-diversity of the oral microbiota.
Conclusion
2
Significant differences are found in intestinal microbiota before and after the occurrence of early gastrointestinal aGVHD in patients after Allo-HSCT
and the occurrence may have a correlation with the chang in oral microbiota.
关键词
Keywords
references
ZEISER R, BLAZAR B R. Acute graft-versus-host disease—biologic process, prevention, and therapy[J]. N Engl J Med, 2017, 377(22): 2167-2179. DOI: 10.1056/nejmra1609337.
NAYMAGON S, NAYMAGON L, WONG S Y, et al . Acute graft-versus-host disease of the gut: considerations for the gastroenterologist[J ] . Nat Rev Gastroenterol Hepatol, 2017, 14(12): 711-726. DOI: 10.1038/nrgastro.2017.126.
SOFI M H, WU Y X, TICER T, et al . A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD[J ] . JCI Insight, 2021, 6(3): e136841. DOI: 10.1172/jci.insight.136841..
FREDRICKS D N. The gut microbiota and graft-versus-host disease[J]. J Clin Investig, 2019, 129(5): 1808-1817. DOI: 10.1172/jci125797.
SWIMM A, GIVER C R, DEFILIPP Z, et al . Indoles derived from intestinal microbiota act via type Ⅰ interferon signaling to limit graft-versus-host disease[J ] . Blood, 2018, 132(23): 2506-2519. DOI: 10.1182/blood-2018-03-838193..
TUGANBAEV T, YOSHIDA K, HONDA K. The effects of oral microbiota on health[J]. Science, 2022, 376(6596): 934-936. DOI: 10.1126/science.abn1890.
OLSEN I, YAMAZAKI K. Can oral bacteria affect the microbiome of the gut?[J]. J Oral Microbiol, 2019, 11(1): 1586422. DOI: 10.1080/20002297.2019.1586422.
ATARASHI K, SUDA W, LUO C W, et al . Ectopic colonization of oral bacteria in the intestine drives T H 1 cell induction and inflammation[J ] . Science, 2017, 358(6361): 359-365. DOI: 10.1126/science.aan4526..
ILLIANO P, BRAMBILLA R, PAROLINI C. The mutual interplay of gut microbiota, diet and human disease[J]. FEBS J, 2020, 287(5): 833-855. DOI: 10.1111/febs.15217.
HAYASE E, HAYASE T, JAMAL M A, et al . Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease[J ] . Cell, 2022, 185(20): 3705-3719. e14. DOI: 10.1016/j.cell.2022.09.007..
ILETT E E, J∅RGENSEN M, NOGUERA-JULIAN M, et al . Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients[J ] . Blood Adv, 2020, 4(22): 5797-5809. DOI: 10.1182/bloodadvances.2020002677.
BURGOS DA SILVA M, PONCE D M, DAI A Q, et al . Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease[J ] . Blood, 2022, 140(22): 2385-2397. DOI: 10.1182/blood.2021015352.
GRECO R, NITTI R, MANCINI N, et al . Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients[J ] . Blood, 2021, 137(11): 1556-1559. DOI: 10.1182/blood.2020007158.
YAZDANDOUST E, HAJIFATHALI A, ROSHANDEL E, et al . Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation[J ] . Transpl Immunol, 2023, 78: 101836. DOI: 10.1016/j.trim.2023.101836.
PACAUD M, COLAS L, BROUARD S. Microbiota and immunoregulation: a focus on regulatory B lymphocytes and transplantation[J]. Am J Transplant, 2021, 21(7): 2341-2347. DOI: 10.1111/ajt.16522.
MATHEWSON N D, JENQ R, MATHEW A V, et al . Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease[J ] . Nat Immunol, 2016, 17(5): 505-513. DOI: 10.1038/ni.3400.
HEIDRICH V, BRUNO J S, KNEBEL F H, et al . Dental biofilm microbiota dysbiosis is associated with the risk of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation[J ] . Front Immunol, 2021, 12: 692225. DOI: 10.3389/fimmu.2021.692225.
LITVAK Y, BYNDLOSS M X, TSOLIS R M, et al . Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction[J ] . Curr Opin Microbiol, 2017, 39: 1-6. DOI: 10.1016/j.mib.2017.07.003..
0
浏览量
0
下载量
0
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
